key: cord-0738327-ugjtdw1b
authors: Xu, Si-Yun; Yang, Li-Li; Qi, Qi; Wang, Xian-Jun; Xie, Yi-Cheng; Zhao, Zheng-Yan; Shu, Qiang
title: Management of children with COVID-19: experiences from China
date: 2020-06-10
journal: World J Pediatr
DOI: 10.1007/s12519-020-00373-1
sha: c3a074c0eb5d6f4b43d9d76a68a7506f5c4ef40b
doc_id: 738327
cord_uid: ugjtdw1b

nan

a review by Ma et al. [4] focusing on the management strategies of neonatal jaundice during the COVID-19 pandemic is also included.

Three research articles cover severe cases, infant cases, and family cluster cases. The first article by Sun et al. [5] presents detailed clinical data of eight severe or critically ill cases with COVID-19. The authors report a cytokine storm in these severe cases, which is even more serious in critically ill cases, which indicates that the early identification of the specific features of severe cases and timely treatment are of vital importance. The next article by Sun et al. [6] retrieves and analyzes the clinical data of 36 infants with COVID-19 in detail, and discovers that lymphocytosis, elevated CD4 and IL-10, and co-infections are common in infants with COVID-19, which are different from adults. In the final article, Ji et al. [7] report two confirmed pediatric cases from two family clusters. The authors describe clinical features and laboratory examination results of the two children, who present with mild symptoms and recover quickly after general and symptomatic treatments. Their study highlights the importance that pediatricians should be vigilant in treating patients with family cluster.

Four viewpoints deserving attention and discussion are concerned with COVID-19-related issues including pharmaceutical care recommendations for antiviral treatments, calling for clinical trial in pediatric patients, children's physical and mental needs during the epidemic, and management workflow of neonates with COVID-19 [8] [9] [10] [11] .

We hope that this issue will provide clinicians with an up-to-date and comprehensive overview of the strategies and management for children with COVID-19, and will provide an exchange platform for global knowledge sharing.

Diagnosis, treatment, and prevention of, 2019 novel coronavirus infection in children: experts' consensus statement

Updated diagnosis, treatment and prevention of COVID-19 in children: experts consensus statement (condensed version of the second edition)

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the, 2019 novel coronavirus

Management strategies of neonatal jaundice during the coronavirus disease 2019, outbreak

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study

SARS-CoV-2 infection in infants under 1 year of age in Wuhan City

Clinical features of pediatric patients with COVID-19: a report of two family cluster cases

Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019

Take precautions beforehand: calling for clinical trials of pediatric drugs for treating coronavirus disease 2019

Response to children's physical and mental needs during the COVID-19 outbreak

What can we learn from neonates with COVID-19?

We would like to take this opportunity to thank all the authors who make great efforts on this special issue. We really appreciate the reviewers' valuable comments and helpful suggestions on the submissions.Author contributions XSY and YLL contributed equally to this paper. All authors reviewed, revised, and approved the final manuscript.